BIO investing in unique radiopharmaceutical platform company, developing radioligands with prolonged tumour retention ...

Adaptive Computation LLC Assessed “Awardable” for DARPA[JR1] ERIS Marketplace – Adaptive Computation LLC, a leading provider ...

BIO investing in unique radiopharmaceutical platform company, developing radioligands with prolonged tumour retention Series A was co-led by 4BIO Capital, founding investor M Ventures, Hadean Ventures ...

Actithera’s radiopharma assets irreversibly bind to their targets, allowing for longer retention of the drug inside tumors.

As part of the strategic plan to broaden its suite of service offerings, Infinity Bio has acquired the assets of Serimmune, Inc., which was founded in 2014 to provide unbiased antibody reactome ...

CAMBRIDGE, Mass., June 12, 2025--Parallel Bio raises $21 million in Series A funding and completes first preclinical trial from immune organoid platform with Centivax.

Series A co-led by founding investor M Ventures and new lead investors Hadean Ventures, Sofinnova Partners, and 4BIO Capital with syndicate including Bioqube Ventures, Surveyor Capital and othersLed ...

Glenn Howerton, longtime co-star of hit series “It’s Always Sunny in Philadelphia,” recently revealed why he almost exited ...

About Syntec Bio Founded in 2021, Syntec Bio is a UK-based biotechnology company developing carbon-neutral bio-production technologies to replace high-emission industrial systems.

Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round attracted prominent leaders in AI ...

Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, today announced that, on July 1, 2025, the company ...

For example, the Swiss firm Bottmedical, which is pioneering the use of bio-based materials to replace traditional ...